| 8001 |
Apheresis |
Allogeneic |
Myelodysplastic Syndrome |
Hematology |
2016 |
Standard Therapy |
Poland |
15 |
| 8002 |
Apheresis |
Allogeneic |
Myelodysplastic Syndrome |
Hematology |
2016 |
Standard Therapy |
Poland |
52 |
| 8003 |
Apheresis |
Allogeneic |
Myelodysplastic Syndrome |
Hematology |
2016 |
Standard Therapy |
Poland |
20 |
| 8004 |
Apheresis |
Allogeneic |
Myelodysplastic Syndrome |
Hematology |
2016 |
Standard Therapy |
Poland |
60 |
| 8005 |
Apheresis |
Allogeneic |
Myelodysplastic Syndrome |
Hematology |
2016 |
Standard Therapy |
Poland |
9 |
| 8006 |
Apheresis |
Allogeneic |
Myelodysplastic Syndrome |
Hematology |
2016 |
Standard Therapy |
Poland |
61 |
| 8007 |
Apheresis |
Allogeneic |
Myelodysplastic Syndrome |
Hematology |
2016 |
Standard Therapy |
Poland |
63 |
| 8008 |
Apheresis |
Allogeneic |
Myelodysplastic Syndrome |
Hematology |
2016 |
Standard Therapy |
Poland |
15 |
| 8009 |
Apheresis |
Allogeneic |
Myelodysplastic Syndrome |
Hematology |
2016 |
Standard Therapy |
Poland |
37 |
| 8010 |
Apheresis |
Allogeneic |
Myelodysplastic Syndrome |
Hematology |
2016 |
Standard Therapy |
Poland |
59 |
| 8011 |
Apheresis |
Allogeneic |
Myelodysplastic Syndrome |
Hematology |
2016 |
Standard Therapy |
Poland |
62 |
| 8012 |
Apheresis |
Allogeneic |
Myelodysplastic Syndrome |
Hematology |
2016 |
Standard Therapy |
Poland |
58 |
| 8013 |
Apheresis |
Allogeneic |
Myelodysplastic Syndrome |
Hematology |
2016 |
Standard Therapy |
Poland |
69 |
| 8014 |
Apheresis |
Allogeneic |
Myelodysplastic Syndrome |
Hematology |
2016 |
Standard Therapy |
Poland |
66 |
| 8015 |
Apheresis |
Allogeneic |
Myelodysplastic Syndrome |
Hematology |
2016 |
Standard Therapy |
Germany |
67 |
| 8016 |
Apheresis |
Allogeneic |
Myelodysplastic Syndrome |
Hematology |
2016 |
Standard Therapy |
Germany |
57 |
| 8017 |
Apheresis |
Allogeneic |
Myelodysplastic Syndrome – Rcmd |
Hematology |
2016 |
Standard Therapy |
Poland |
32 |
| 8018 |
Apheresis |
Allogeneic |
Myelodysplastic Syndrome – Raeb |
Hematology |
2016 |
Standard Therapy |
Poland |
56 |
| 8019 |
Apheresis |
Allogeneic |
Myelofibrosis |
Hematology |
2016 |
Standard Therapy |
Poland |
72 |
| 8020 |
Apheresis |
Allogeneic |
Myelofibrosis |
Hematology |
2016 |
Standard Therapy |
Poland |
66 |
| 8021 |
Apheresis |
Allogeneic |
Myelofibrosis |
Hematology |
2016 |
Standard Therapy |
Poland |
67 |
| 8022 |
Apheresis |
Allogeneic |
Myeloma Multiplex |
Hematology |
2016 |
Standard Therapy |
Poland |
63 |
| 8023 |
Apheresis |
Allogeneic |
Myeloma Multiplex |
Hematology |
2016 |
Standard Therapy |
Poland |
51 |
| 8024 |
Apheresis |
Allogeneic |
Myeloma Multiplex |
Hematology |
2016 |
Standard Therapy |
Poland |
38 |
| 8025 |
Apheresis |
Allogeneic |
Myeloproliferative Syndrome |
Hematology |
2016 |
Standard Therapy |
Poland |
52 |
| 8026 |
Apheresis |
Allogeneic |
Myeloproliferative Syndrome |
Hematology |
2016 |
Standard Therapy |
Germany |
63 |
| 8027 |
Apheresis |
Autologous |
Neuroblastoma |
Hematology |
2016 |
Standard Therapy |
Germany |
5 |
| 8028 |
Apheresis |
Allogeneic |
No Data |
no data |
2016 |
Standard Therapy |
Poland |
45 |
| 8029 |
Apheresis |
Allogeneic |
No Data |
no data |
2016 |
Standard Therapy |
Poland |
70 |
| 8030 |
Apheresis |
Allogeneic |
No Data |
no data |
2016 |
Standard Therapy |
Poland |
43 |
| 8031 |
Apheresis |
Allogeneic |
No Data |
no data |
2016 |
Standard Therapy |
Poland |
69 |
| 8032 |
Apheresis |
Allogeneic |
No Data |
no data |
2016 |
Standard Therapy |
Poland |
28 |
| 8033 |
Apheresis |
Allogeneic |
No Data |
no data |
2016 |
Standard Therapy |
Poland |
1 |
| 8034 |
Apheresis |
Allogeneic |
No Data |
no data |
2016 |
Standard Therapy |
Poland |
30 |
| 8035 |
Apheresis |
Allogeneic |
No Data |
no data |
2016 |
Standard Therapy |
Poland |
71 |
| 8036 |
Apheresis |
Allogeneic |
No Data |
no data |
2016 |
Standard Therapy |
Poland |
58 |
| 8037 |
Apheresis |
Allogeneic |
No Data |
no data |
2016 |
Standard Therapy |
Poland |
17 |
| 8038 |
Apheresis |
Allogeneic |
No Data |
no data |
2016 |
Standard Therapy |
Poland |
59 |
| 8039 |
Apheresis |
Allogeneic |
No Data |
no data |
2016 |
Standard Therapy |
Poland |
58 |
| 8040 |
Apheresis |
Allogeneic |
No Data |
no data |
2016 |
Standard Therapy |
Poland |
55 |
| 8041 |
Apheresis |
Allogeneic |
No Data |
no data |
2016 |
Standard Therapy |
Poland |
44 |
| 8042 |
Apheresis |
Allogeneic |
Non-Hodgkin Lymphoma |
Hematology |
2016 |
Standard Therapy |
Poland |
38 |
| 8043 |
Apheresis |
Allogeneic |
Non-Hodgkin Lymphoma |
Hematology |
2016 |
Standard Therapy |
Poland |
58 |
| 8044 |
Apheresis |
Allogeneic |
Non-Hodgkin Lymphoma |
Hematology |
2016 |
Standard Therapy |
Poland |
32 |
| 8045 |
Apheresis |
Allogeneic |
Non-Hodgkin Lymphoma |
Hematology |
2016 |
Standard Therapy |
Poland |
39 |
| 8046 |
Apheresis |
Autologous |
Non-Hodgkin Lymphoma |
Hematology |
2016 |
Standard Therapy |
Germany |
61 |
| 8047 |
Apheresis |
Autologous |
Non-Hodgkin Lymphoma |
Hematology |
2016 |
Standard Therapy |
Germany |
73 |
| 8048 |
Apheresis |
Autologous |
Non-Hodgkin Lymphoma |
Hematology |
2016 |
Standard Therapy |
Germany |
27 |
| 8049 |
Apheresis |
Autologous |
Non-Hodgkin Lymphoma |
Hematology |
2016 |
Standard Therapy |
Germany |
65 |
| 8050 |
Apheresis |
Autologous |
Non-Hodgkin Lymphoma |
Hematology |
2016 |
Standard Therapy |
Germany |
61 |
| 8051 |
Apheresis |
Allogeneic |
Plasma Cell Disorder |
Hematology |
2016 |
Standard Therapy |
Poland |
47 |
| 8052 |
Apheresis |
Autologous |
Plasmacytoma |
Hematology |
2016 |
Standard Therapy |
Germany |
58 |
| 8053 |
Apheresis |
Autologous |
Plasmacytoma |
Hematology |
2016 |
Standard Therapy |
Germany |
68 |
| 8054 |
Apheresis |
Autologous |
Plasmacytoma |
Hematology |
2016 |
Standard Therapy |
Germany |
48 |
| 8055 |
Apheresis |
Autologous |
Primary Central Nervous System Lymphoma |
Hematology |
2016 |
Standard Therapy |
Germany |
62 |
| 8056 |
Apheresis |
Autologous |
Primary Central Nervous System Lymphoma |
Hematology |
2016 |
Standard Therapy |
Germany |
51 |
| 8057 |
Apheresis |
Autologous |
Primary Central Nervous System Lymphoma |
Hematology |
2016 |
Standard Therapy |
Germany |
62 |
| 8058 |
Apheresis |
Allogeneic |
Primary Immunodeficiency |
Hematology |
2016 |
Standard Therapy |
Poland |
5 |
| 8059 |
Apheresis |
Allogeneic |
Primary Myelofibrosis |
Hematology |
2016 |
Standard Therapy |
Poland |
50 |
| 8060 |
Apheresis |
Allogeneic |
Primary Myelofibrosis |
Hematology |
2016 |
Standard Therapy |
Poland |
67 |
| 8061 |
Apheresis |
Allogeneic |
Primary Myelofibrosis |
Hematology |
2016 |
Standard Therapy |
Poland |
67 |
| 8062 |
Apheresis |
Allogeneic |
Primary Myelofibrosis |
Hematology |
2016 |
Standard Therapy |
Germany |
56 |
| 8063 |
Apheresis |
Allogeneic |
Primary Myelofibrosis |
Hematology |
2016 |
Standard Therapy |
Germany |
58 |
| 8064 |
Apheresis |
Allogeneic |
Refractory Anemia With Excess Blasts |
Hematology |
2016 |
Standard Therapy |
Poland |
62 |
| 8065 |
Apheresis |
Allogeneic |
Severe Aplastic Anemia / Amyloidosis |
Hematology |
2016 |
Standard Therapy |
Poland |
45 |
| 8066 |
Apheresis |
Allogeneic |
Secondary Acute Myeloid Leukemia At Myeloproliferative Syndrome |
Hematology |
2016 |
Standard Therapy |
Germany |
28 |
| 8067 |
Apheresis |
Allogeneic |
Severe Aplastic Anemia |
Hematology |
2016 |
Standard Therapy |
Poland |
18 |
| 8068 |
Apheresis |
Autologous |
Small Cell Ovarian Carcinoma |
Hematology |
2016 |
Standard Therapy |
Germany |
18 |
| 8069 |
Apheresis |
Allogeneic |
T Cell Lymphoma/ Nos – Not Otherwise Specified |
Hematology |
2016 |
Standard Therapy |
Poland |
55 |
| 8070 |
Apheresis |
Allogeneic |
T-Cell Acute Lymphoblastic Leukemia |
Hematology |
2016 |
Standard Therapy |
Poland |
19 |
| 8071 |
Apheresis |
Allogeneic |
T-Cell Acute Lymphoblastic Leukemia |
Hematology |
2016 |
Standard Therapy |
Poland |
21 |
| 8072 |
Apheresis |
Allogeneic |
T-Cell Acute Lymphoblastic Leukemia |
Hematology |
2016 |
Standard Therapy |
Poland |
41 |
| 8073 |
Apheresis |
Allogeneic |
T-Cell Leukemia/Lymphoma |
Hematology |
2016 |
Standard Therapy |
Poland |
31 |
| 8074 |
Apheresis |
Autologous |
T-Cell Non-Hodgkin Lymphoma |
Hematology |
2016 |
Standard Therapy |
Germany |
48 |
| 8075 |
Apheresis |
Allogeneic |
T-Cell Non-Hodgkin Lymphoma |
Hematology |
2016 |
Standard Therapy |
Germany |
24 |
| 8076 |
Apheresis |
Autologous |
T-Cell-Lymphoma |
Hematology |
2016 |
Standard Therapy |
Germany |
55 |
| 8077 |
Apheresis |
Autologous |
T-Cell-Lymphoma |
Hematology |
2016 |
Standard Therapy |
Germany |
33 |
| 8078 |
Apheresis |
Allogeneic |
T-Cell-Prolymphocytic Leukemia |
Hematology |
2016 |
Standard Therapy |
Poland |
61 |
| 8079 |
Apheresis |
Allogeneic |
Wiskott-Aldrich Syndrome |
Hematology |
2016 |
Standard Therapy |
Poland |
1 |
| 8080 |
Apheresis |
Allogeneic |
X-Linked Lymphoproliferative Disease |
Hematology |
2016 |
Standard Therapy |
Poland |
12 |
| 8081 |
Cord Tissue |
Allogeneic – Unrelated |
Acute Graft Versus Host Disease |
Hematology |
2015 |
Experimental Therapy |
Poland |
1,4 |
| 8082 |
Cord Tissue |
Allogeneic – Unrelated |
Acute Graft Versus Host Disease |
Hematology |
2015 |
Experimental Therapy |
Poland |
11 months |
| 8083 |
Cord Tissue |
Allogeneic – Unrelated |
Acute Graft Versus Host Disease |
Hematology |
2015 |
Experimental Therapy |
Poland |
51,5 |
| 8084 |
Cord Tissue |
Allogeneic – Unrelated |
Acute Graft Versus Host Disease |
Hematology |
2015 |
Experimental Therapy |
Poland |
6,6 |
| 8085 |
Cord Tissue |
Allogeneic – Unrelated |
Acute Graft Versus Host Disease |
Hematology |
2015 |
Experimental Therapy |
Poland |
13,4 |
| 8086 |
Cord Tissue |
Allogeneic – Unrelated |
Adrenoleukodystrophy; Encephalopathy |
Neurology |
2015 |
Experimental Therapy |
Poland |
23 |
| 8087 |
Cord Tissue |
Allogeneic – Unrelated |
Amyotrophic Lateral Sclerosis |
Neurology |
2015 |
Experimental Therapy |
Poland |
61,6 |
| 8088 |
Cord Tissue |
Allogeneic – Unrelated |
Amyotrophic Lateral Sclerosis |
Neurology |
2015 |
Experimental Therapy |
Poland |
61 |
| 8089 |
Cord Tissue |
Allogeneic – Unrelated |
Amyotrophic Lateral Sclerosis |
Neurology |
2015 |
Experimental Therapy |
Poland |
56 |
| 8090 |
Cord Tissue |
Allogeneic – Unrelated |
Amyotrophic Lateral Sclerosis |
Neurology |
2015 |
Experimental Therapy |
Poland |
51 |
| 8091 |
Cord Tissue |
Allogeneic – Unrelated |
Amyotrophic Lateral Sclerosis |
Neurology |
2015 |
Experimental Therapy |
Poland |
65 |
| 8092 |
Cord Tissue |
Allogeneic – Unrelated |
Amyotrophic Lateral Sclerosis |
Neurology |
2015 |
Experimental Therapy |
Poland |
60 |
| 8093 |
Cord Tissue |
Allogeneic – Unrelated |
Amyotrophic Lateral Sclerosis |
Neurology |
2015 |
Experimental Therapy |
Poland |
52 |
| 8094 |
Cord Tissue |
Allogeneic – Unrelated |
Amyotrophic Lateral Sclerosis |
Neurology |
2015 |
Experimental Therapy |
Poland |
59,4 |
| 8095 |
Cord Tissue |
Allogeneic – Unrelated |
Amyotrophic Lateral Sclerosis |
Neurology |
2015 |
Experimental Therapy |
Poland |
61,5 |
| 8096 |
Cord Tissue |
Allogeneic – Unrelated |
Amyotrophic Lateral Sclerosis |
Neurology |
2015 |
Experimental Therapy |
Poland |
58 |
| 8097 |
Cord Tissue |
Allogeneic – Unrelated |
Amyotrophic Lateral Sclerosis |
Neurology |
2015 |
Experimental Therapy |
Poland |
61,6 |
| 8098 |
Cord Tissue |
Allogeneic – Unrelated |
Amyotrophic Lateral Sclerosis |
Neurology |
2015 |
Experimental Therapy |
Poland |
62 |
| 8099 |
Cord Tissue |
Allogeneic – Unrelated |
Amyotrophic Lateral Sclerosis |
Neurology |
2015 |
Experimental Therapy |
Poland |
26,5 |
| 8100 |
Cord Tissue |
Allogeneic – Unrelated |
Amyotrophic Lateral Sclerosis |
Neurology |
2015 |
Experimental Therapy |
Poland |
27 |